Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Pension (2021 - 2023)

Neuphoria Therapeutics (NEUP) reported Pension of $14969.9 for Q2 2023, up 99.81% year-over-year from $7492.2 in Q2 2022, and up 99.81% on a QoQ basis from $7492.2 in Q2 2022.

Neuphoria Therapeutics (NEUP) has 3 years of Pension data on file, last reported at $14969.9 in Q2 2023.

  • Quarterly Pension rose 99.81% year-over-year to $14969.9 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $14969.9 (up 99.81% YoY) and the FY2023 annual result came in at $14969.9, up 99.81% from the prior year.
  • Pension advanced to $14969.9 in Q2 2023 per NEUP's latest filing, from $7492.2 in the prior quarter.
  • Across five years, Pension topped out at $14969.9 in Q2 2023 and bottomed at $5222.5 in Q2 2021.
  • The 3-year median for Pension is $7492.2 (2022), against an average of $9228.2.
  • The widest annual swing landed in 2022, when Pension soared 43.46%; it then soared 99.81% in 2023.
  • Tracing NEUP's Pension over 3 years: stood at $5222.5 in 2021, then soared by 43.46% to $7492.2 in 2022, then soared by 99.81% to $14969.9 in 2023.
  • Per Business Quant, the three latest NEUP Pension figures stand at $14969.9 (Q2 2023), $7492.2 (Q2 2022), and $5222.5 (Q2 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Neuphoria Therapeutics 28.35 Mn 8.95 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 14,969.94
Jun 30, 2022 7,492.17
Jun 30, 2021 5,222.51